Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good
2006
Toward a treaty on safety and cost-effectiveness of pharmaceuticals and medical devices
publication
Evidence: moderate
Author Information
Author(s): Thomas Alured Faunce
Primary Institution: Australian National University
Hypothesis
Can states negotiate a multilateral treaty on the safety, efficacy, and cost-effectiveness of pharmaceuticals and medical devices?
Conclusion
The study suggests that a multilateral treaty could enhance the safety and cost-effectiveness of pharmaceuticals and medical devices globally.
Supporting Evidence
- Expert evaluations of pharmaceuticals and medical devices are crucial for public safety.
- Countries like Australia and Canada have established successful cost-effectiveness analysis systems.
- International organizations are increasingly scrutinizing the safety and efficacy of medical products.
Takeaway
This study talks about how countries can work together to make sure medicines and medical devices are safe and affordable for everyone.
Potential Biases
Potential influence from multinational pharmaceutical companies on regulatory processes.
Limitations
The paper does not provide specific empirical data to support its claims.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website